发明名称 |
Humanized FcgammaR Mice |
摘要 |
Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion of the endogenous low affinity FcγR locus, and wherein the mouse is capable of expressing a functional FcRγ-chain. Genetically modified mice are described, including mice that express low affinity human FcγR genes from the endogenous FcγR locus, and wherein the mice comprise a functional FcRγ-chain. Genetically modified mice that express up to five low affinity human FcγR genes on accessory cells of the host immune system are provided. |
申请公布号 |
US2015024412(A1) |
申请公布日期 |
2015.01.22 |
申请号 |
US201414508782 |
申请日期 |
2014.10.07 |
申请人 |
Regeneron Pharmaceuticals, Inc. |
发明人 |
Macdonald Lynn;Tu Naxin;Gurer Cagan;Wang Li-Hsien;Stevens Sean;Murphy Andrew J. |
分类号 |
C07K14/735;G01N33/569 |
主分类号 |
C07K14/735 |
代理机构 |
|
代理人 |
|
主权项 |
1. A mouse lymphocyte comprising in its genome at least two low affinity human FcγR α-chain genes that replace the endogenous mouse low affinity FcγR α-chain genes, wherein the cell comprises a functional FcR γ-chain and functionally expresses the at least two low affinity human FcγR α-chain genes. |
地址 |
Tarrytown NY US |